Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Gains 5%; BSE HEALTHCARE Index Down 0.3%
Mon, 9 Sep 9:28

ALEMBIC PHARMA Gains 5%; BSE HEALTHCARE Index Down 0.3%Image source: asbe/www.istockphoto.com

ALEMBIC PHARMA share price has zoomed 5% and is presently trading at Rs 1,160.6.

Meanwhile, the BSE HEALTHCARE index is at 43,328.7 (down 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are HIKAL CHEMIC (up 2.7%) and ERIS LIFESCIENCES (up 1.4%).

GRANULES INDIA (down 3.5%) and AJANTA PHARMA (down 2.1%) are among the top losers today.

Over the last one year, ALEMBIC PHARMA has moved up from Rs 776.9 to Rs 1,160.6, registering a gain of Rs 383.7 (up 49.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,163.1 to 43,328.7, registering a gain of 53.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 139.3%), Glenmark Pharma (up 116.8%) and GRANULES INDIA (up 113.3%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,079.0 (down 0.1%).

The top losers among the BSE Sensex today are Tata Steel (down 1.3%) and Power Grid Corp. (down 1.1%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.

In the meantime, NSE Nifty is at 24,813.7 (down 0.2%). ONGC and Tata Steel are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,780.3 to 81,079.0, registering a gain of 15,298.8 points (up 23.3%).

ALEMBIC PHARMA Financial Update...

ALEMBIC PHARMA net profit grew 11.3% YoY to Rs 1,342 million for the quarter ended June 2024, compared to a profit of Rs 1,206 million a year ago. Net sales rose 5.1% to Rs 15,617 million during the period as against Rs 14,862 million in April-June 2023.

For the year ended March 2024, ALEMBIC PHARMA reported 80.1% increase in net profit to Rs 6,158 million compared to net profit of Rs 3,420 million during FY23. Revenue of the company grew 10.2% to Rs 62,286 million during FY24.

The current Price to earnings ratio of ALEMBIC PHARMA, based on rolling 12 month earnings, stands at 36.2.


Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Gains 5%; BSE HEALTHCARE Index Down 0.3%". Click here!